证券代码：002243 证券简称：力合科创 公告编号：2025-028号 深圳市力合科创股份有限公司 关于召开 2025 年第一次临时股东大会的通知 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 深圳市力合科创股份有限公司（以下简称"公司"）第六届董事会第十五次会 议于 2025 年 5 月 22 日审议通过了《关于召开 2025 年第一次临时股东大会的议 案》，公司董事会决定于 2025 年 6 月 9 日（星期一）以现场表决和网络投票相结 合的方式召开公司 2025 年第一次临时股东大会。现就召开本次股东大会的有关事 项通知如下： 一、召开会议的基本情况 1、股东大会届次：2025 年第一次临时股东大会 2、会议召集人：公司第六届董事会 3、会议召开的合法、合规性：本次股东大会会议的召开符合有关法律、行政 法规、部门规章、规范性文件和《公司章程》的有关规定。 4、会议召开日期和时间 （1）现场会议：2025 年 6 月 9 日（星期一）14:30 （2）网络投票时间： 通过深圳证券交易所交易系统进行网络投票的具体时间为 2025 年 6 月 9 日 9: ...

证券代码：002243 证券简称：力合科创 公告编号：2025-029号 深圳市力合科创股份有限公司 第六届监事会第十五次会议决议公告 一、会议以 3 票同意、0 票反对、0 票弃权，审议并通过了《关于控股子公 司以自有资产抵押向银行申请授信额度的议案》； 二、会议以 3 票同意、0 票反对、0 票弃权，审议并通过了《关于为全资子 公司提供财务资助的议案》。 特此公告。 深圳市力合科创股份有限公司监事会 2025 年 5 月 23 日 本公司及监事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 深圳市力合科创股份有限公司（以下简称"公司"）第六届监事会第十五次 会议于 2025 年 5 月 22 日以现场方式召开。本次监事会会议通知已于 2025 年 5 月 16 日以电子邮件方式送达。本次应参加会议监事 3 人，实际参加会议监事 3 人。本次会议由监事会主席刘彦孜女士召集和主持，会议的内容以及召集、召开 的方式、程序均符合《公司法》和《公司章程》的规定。经全体与会监事表决， 一致通过以下决议： ...

证券代码：002243 证券简称：力合科创 公告编号：2025-025号 一、会议以 8 票同意、0 票反对、0 票弃权，审议并通过了《关于聘任公司总 经理的议案》； 经董事长贺臻先生推荐，董事会提名委员会审查，同意聘任徐安毕先生（简历 详见公告）为公司总经理，任期自董事会审议通过之日起至公司第六届董事会届满 之日止。 深圳市力合科创股份有限公司 第六届董事会第十五次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 深圳市力合科创股份有限公司（以下简称"公司"）第六届董事会第十五次会 议于 2025 年 5 月 22 日以现场方式召开。本次董事会会议通知已于 2025 年 5 月 16 日以电子邮件方式送达给全体董事、监事和高级管理人员。本次应参加会议的董事 8 人，实际参加会议的董事 8 人。本次会议由董事长贺臻先生召集和主持，公司全 体监事、高级管理人员列席了本次会议。会议的内容以及召集、召开的方式、程序 均符合《公司法》和《公司章程》的规定。经全体与会董事表决，通过以下决议： 《关于控股子公司以自有资产抵押向银行申请授信额度的公告》刊登在 2 ...

Group 1 - The 2025 Global Artificial Intelligence Terminal Exhibition and the 6th Shenzhen International Artificial Intelligence Exhibition will take place from May 22 to 24, featuring over 25,000 square meters of exhibition space, 20+ professional forums, 100+ experts, and 50,000+ professional visitors, showcasing the latest achievements and future trends in AI technology and smart terminal products [1] - The exhibition will focus on nine categories of AI terminals, including AI smartphones, AI PCs, AI tablets, large model integrated machines, AI wearable devices, AI imaging devices, whole-home smart products, industrial-grade AI terminals, and other new AI terminals, creating a comprehensive display matrix of "core technology - terminal products - large model applications" [1] - The event aims to provide a platform for small and medium-sized enterprises to showcase innovative products, allowing attendees to experience cutting-edge technology and explore investment opportunities in the AI sector [2] Group 2 - The exhibition will feature a "Financial + Technology + Industry" matrix, with several investment institutions participating alongside their AI portfolio companies, facilitating efficient communication and collaboration between financial institutions and tech companies [2] - The 2025 Global Artificial Intelligence Terminal Exhibition will be held concurrently with the Cultural Expo, enhancing the synergy between the two events and showcasing key innovations in AI terminals, such as Hongmeng PCs and Thunder AI glasses [3] - A dedicated area for robots and human-machine interaction will be established, allowing attendees to experience the intersection of technology and culture, highlighting the potential of human-robot collaboration [3]

证券代码：002243 证券简称：力合科创 公告编号：2025-024号 深圳市力合科创股份有限公司 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 深圳市力合科创股份有限公司（以下简称"公司"）2024 年度利润分配方案 （以下简称"分配方案"）已获 2025 年 4 月 16 日召开的 2024 年度股东大会审议 通过，现将分红派息实施事宜公告如下： 三、分红派息日期 （含税；扣税后，通过深股通持有股份的 香港市场投资者、境外机构（ （含 QFII、RQFII）以及持有首发前限售股的个人和证 券投资基金每 10 股派 0.63 元；持有首发后限售股、股权激励限售股及无限售流 通股的个人股息红利税实行差别化税率征收，本公司暂不扣缴个人所得税，待个人 转让股票时，根据其持股期限计算应纳税额（ 注】；持有首发后限售股、股权激励 限售股及无限售流通股的证券投资基金所涉红利税，对香港投资者持有基金份额 部分按 10%征收，对内地投资者持有基金份额部分实行差别化税率征收）。 注：根据先进先出的原则，以投资者证券账户为单位计算持股期限，持股 1 个月（ （含 1 个月） ...

深圳市力合科创股份有限公司 2024 年度分红派息实施公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 证券代码：002243 证券简称：力合科创 公告编号：2025-024号 深圳市力合科创股份有限公司（以下简称"公司"）2024 年度利润分配方案 （以下简称"分配方案"）已获 2025 年 4 月 16 日召开的 2024 年度股东大会审议 通过，现将分红派息实施事宜公告如下： 一、股东大会审议通过利润分配方案等情况 1、2024 年度利润分配方案为：以 1,210,604,219 股为基数，向全体股东每 10 股派发现金红利 0.7 元（含税），不送红股，也不以公积金转增股本。 2、本次分配方案披露至实施期间公司股本总额未发生变化。若在分配方案实 施前公司总股本发生变化，将按照现金分红分配总额固定不变的原则进行调整。 3、本次实施的分配方案与 2024 年度股东大会审议通过的分配方案一致。 4、本次分配方案实施距离股东大会审议通过的时间未超过两个月。 二、本次实施的利润分配方案 公司 2024 年度利润分配方案为：以公司现有总股本 1,210,604 ...

Core Viewpoint - The article discusses the significant rise of state-owned capital (国资) in China's primary market, highlighting its role as a major investor and the evolving dynamics of investment strategies in the context of government policies and economic development [1][2]. Group 1: Policy Guidance - The core guidance for the development of state-owned capital in equity investment stems from top-level policies, which have evolved since the establishment of national investment companies in 1988 [12]. - The establishment of local investment companies surged after the State-owned Assets Supervision and Administration Commission (SASAC) was formed in 2003, leading to a proliferation of state-owned investment entities [12][14]. - Recent policies emphasize the need for "patient capital" and the prohibition of preferential treatment for specific operators, aiming to enhance the quality of government investment funds [5][6]. Group 2: Investment Dynamics - From 2014 to 2023, the proportion of government capital in newly raised RMB funds increased from 20% to 41%, indicating a shift towards state-owned capital as a primary funding source [2]. - State-owned capital is characterized by its dual focus on investment returns and local economic development, often requiring a balance between investment, risk, and local job creation [4][7]. - The investment strategies of state-owned entities are increasingly aligned with national economic goals, focusing on sectors like technology and innovation [6][7]. Group 3: Case Studies - Beijing E-Town International Investment Development Co., known as "亦庄国投," has invested significantly in the digital television and integrated circuit industries, demonstrating a model of leveraging state capital for local industrial development [16][17]. - The Xiong'an Group, established to support the development of the Xiong'an New Area, has focused on introducing key industries and managing multiple funds to drive local economic growth [20][21]. - Hefei Construction Investment Group has successfully transformed Hefei's industrial landscape by investing in leading companies like BOE Technology Group, resulting in a significant increase in local production capacity [43][44]. Group 4: Market Integration - The integration of state-owned capital into the market has led to the establishment of various funds aimed at fostering innovation and supporting emerging industries [50][51]. - The restructuring of state-owned investment entities in cities like Shanghai aims to eliminate redundancy and enhance the efficiency of capital allocation [56][58]. - The article highlights the importance of top-level coordination in optimizing the roles of different state-owned investment bodies to avoid overlapping functions and improve overall investment effectiveness [51][52].

Company Overview - Axbio International Limited, referred to as "安序源", is a global leader in integrated circuit biotechnology, established in 2016, focusing on developing next-generation electrochemical detection platforms for life sciences tools and diagnostics [3]. - The company integrates integrated circuits, biotechnology, and artificial intelligence technologies to create advanced foundational platforms for life science research and clinical applications [3]. Product Pipeline - As of April 21, 2025, Axbio's product pipeline includes a microarray chip analyzer, two EL-NGS gene sequencers, and various supporting test kits [3]. - The core product, AxiLona EL-100, has received registration approval from the Jiangsu Provincial Drug Administration [3]. Financial Performance - For the fiscal year ending December 31, 2023, Axbio reported zero revenue, with a net loss of $22.86 million. In 2024, projected revenue is $479,000, with an expected net loss of $23.47 million [4]. - The company has incurred research and development expenses of $15.29 million in 2023 and $11.41 million in 2024 [4]. Funding and Valuation - Axbio has undergone multiple funding rounds since its inception, including a $20 million funding round in October 2021, resulting in a post-money valuation of $239 million, and a $70 million funding round in March 2023, with a post-money valuation of $348 million [5]. - The company has a diverse shareholder structure, with Dr. Hui Tian holding 30.44% and Dr. Igor Ivanov holding 15.22% of the shares [6][8]. Shareholder Structure - The major shareholders include Dr. Hui Tian (30.44%), Dr. Igor Ivanov (15.22%), and several investment funds, including AstraZeneca-CICC and YF Digital Health, each holding 5.91% [6][8]. - The total number of shares held by various stakeholders amounts to 181,440,701 shares, representing 100% of the issued share capital [7].

Group 1: Industry Outlook and Policy Environment - The company aims to leverage policy opportunities from the Chinese government's focus on capital market reform and venture capital ecosystem optimization, with a commitment to technological self-reliance and productivity enhancement [2] - In 2024, the government is expected to introduce multiple policies to support these initiatives [2] Group 2: Investment Focus Areas - The company's investment strategy concentrates on sectors such as new energy materials, next-generation information technology, biomedicine, and advanced manufacturing [3] - Key incubated companies include Hydrogen Energy, Nano Fluor Technology, Lanyi Aviation, and others, covering niches like seawater hydrogen production and electric vertical take-off and landing aircraft [3] Group 3: Collaboration with Academia - The company has established a collaborative incubation system with institutions like Tsinghua University and Hong Kong University of Science and Technology, focusing on technology transfer agreements [4] - In 2024, the company completed its first technology transfer project with Hong Kong University, involving innovations from several universities [4] Group 4: Investment Returns and Exit Strategies - The company emphasizes the importance of project exits, utilizing methods such as equity transfers, mergers, and secondary market reductions [3] - In 2024, the company successfully recouped approximately CNY 180 million from direct investments and managed fund projects [3] Group 5: Concept Validation Fund - The company has over 20 years of experience in technology innovation services, creating a unique advantage in resource allocation and industry cultivation [4] - The concept validation fund assists early-stage technology projects by providing funding and guidance, enhancing the success rate of technology commercialization [4]

据证券之星公开数据整理，近期力合科创(002243)发布2025年一季报。截至本报告期末，公司营业总收 入4.67亿元，同比上升5.18%，归母净利润-2070.05万元，同比上升42.64%。按单季度数据看，第一季度 营业总收入4.67亿元，同比上升5.18%，第一季度归母净利润-2070.05万元，同比上升42.64%。本报告期 力合科创盈利能力上升，毛利率同比增幅16.34%，净利率同比增幅40.35%。 本次财报公布的各项数据指标表现尚佳。其中，毛利率19.09%，同比增16.34%，净利率-7.59%，同比 增40.35%，销售费用、管理费用、财务费用总计1.03亿元，三费占营收比22.12%，同比减4.41%，每股 净资产6.0元，同比增2.03%，每股经营性现金流0.05元，同比增135.2%，每股收益-0.02元，同比增 42.62% 最近有知名机构关注了公司以下问题： 问：应收账款占净利润比例较高，公司计划采取哪些措施优化应收账款管理并提升现金流回速度？ 答:尊敬的投资者，您好。公司的应收账款同比有所下降且大部分在信用账期内，下一步公司将加强客 户信用管理和催收机制等措施，加大应收账款回收力 ...